CVS Health Corporation (0HRS.L)
USD 65.15
(-3.81%)
USD 65.15
(-3.81%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 8.34 Billion USD | 93.55% |
| 2022 | 4.31 Billion USD | -46.12% |
| 2021 | 8 Billion USD | 11.45% |
| 2020 | 7.17 Billion USD | 8.22% |
| 2019 | 6.63 Billion USD | 1216.84% |
| 2018 | -594 Million USD | -108.97% |
| 2017 | 6.62 Billion USD | 24.54% |
| 2016 | 5.31 Billion USD | 1.53% |
| 2015 | 5.23 Billion USD | 12.77% |
| 2014 | 4.64 Billion USD | 1.13% |
| 2013 | 4.59 Billion USD | 18.44% |
| 2012 | 3.87 Billion USD | 12.02% |
| 2011 | 3.46 Billion USD | 0.99% |
| 2010 | 3.42 Billion USD | -7.28% |
| 2009 | 3.69 Billion USD | 15.06% |
| 2008 | 3.21 Billion USD | 21.81% |
| 2007 | 2.63 Billion USD | 92.64% |
| 2006 | 1.36 Billion USD | 11.77% |
| 2005 | 1.22 Billion USD | 33.29% |
| 2004 | 918.8 Million USD | 8.44% |
| 2003 | 847.3 Million USD | 18.24% |
| 2002 | 716.6 Million USD | 73.43% |
| 2001 | 413.2 Million USD | -44.61% |
| 2000 | 746 Million USD | 17.46% |
| 1999 | 635.1 Million USD | 60.22% |
| 1998 | 396.4 Million USD | 951.46% |
| 1997 | 37.7 Million USD | -50.0% |
| 1996 | 75.4 Million USD | 111.47% |
| 1995 | -657.2 Million USD | -313.72% |
| 1994 | 307.5 Million USD | -7.32% |
| 1993 | 331.8 Million USD | 148.73% |
| 1992 | 133.4 Million USD | -61.52% |
| 1991 | 346.7 Million USD | -10.02% |
| 1990 | 385.3 Million USD | -3.22% |
| 1989 | 398.1 Million USD | 12.3% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.11 Billion USD | -45.6% |
| 2024 Q2 | 1.77 Billion USD | 59.03% |
| 2023 Q1 | 2.13 Billion USD | -7.21% |
| 2023 Q4 | 2.04 Billion USD | -9.51% |
| 2023 FY | 8.34 Billion USD | 93.55% |
| 2023 Q3 | 2.26 Billion USD | 18.94% |
| 2023 Q2 | 1.9 Billion USD | -11.0% |
| 2022 Q1 | 2.31 Billion USD | 77.03% |
| 2022 FY | 4.31 Billion USD | -46.12% |
| 2022 Q4 | 2.3 Billion USD | 167.59% |
| 2022 Q2 | 2.95 Billion USD | 27.64% |
| 2022 Q3 | -3.4 Billion USD | -215.42% |
| 2021 Q1 | 2.22 Billion USD | 128.47% |
| 2021 Q3 | 1.59 Billion USD | -42.58% |
| 2021 FY | 8 Billion USD | 11.45% |
| 2021 Q4 | 1.3 Billion USD | -18.27% |
| 2021 Q2 | 2.78 Billion USD | 25.19% |
| 2020 Q3 | 1.22 Billion USD | -58.86% |
| 2020 FY | 7.17 Billion USD | 8.22% |
| 2020 Q1 | 2 Billion USD | 14.88% |
| 2020 Q2 | 2.97 Billion USD | 48.23% |
| 2020 Q4 | 973 Million USD | -20.51% |
| 2019 Q4 | 1.74 Billion USD | 14.18% |
| 2019 FY | 6.63 Billion USD | 1216.84% |
| 2019 Q1 | 1.42 Billion USD | 439.14% |
| 2019 Q2 | 1.93 Billion USD | 36.24% |
| 2019 Q3 | 1.53 Billion USD | -20.97% |
| 2018 Q4 | -419 Million USD | -130.14% |
| 2018 FY | -594 Million USD | -108.97% |
| 2018 Q3 | 1.39 Billion USD | 154.23% |
| 2018 Q1 | 998 Million USD | -69.64% |
| 2018 Q2 | -2.56 Billion USD | -356.81% |
| 2017 Q2 | 1.09 Billion USD | 15.34% |
| 2017 Q4 | 3.28 Billion USD | 155.8% |
| 2017 Q3 | 1.28 Billion USD | 17.03% |
| 2017 FY | 6.62 Billion USD | 24.54% |
| 2017 Q1 | 952 Million USD | -44.23% |
| 2016 FY | 5.31 Billion USD | 1.53% |
| 2016 Q3 | 1.54 Billion USD | 66.67% |
| 2016 Q2 | 924 Million USD | -19.37% |
| 2016 Q1 | 1.14 Billion USD | -23.5% |
| 2016 Q4 | 1.7 Billion USD | 10.84% |
| 2015 Q2 | 1.27 Billion USD | 4.18% |
| 2015 FY | 5.23 Billion USD | 12.77% |
| 2015 Q3 | 1.24 Billion USD | -2.04% |
| 2015 Q4 | 1.49 Billion USD | 20.22% |
| 2015 Q1 | 1.22 Billion USD | -7.57% |
| 2014 FY | 4.64 Billion USD | 1.13% |
| 2014 Q3 | 948 Million USD | -23.92% |
| 2014 Q2 | 1.24 Billion USD | 10.36% |
| 2014 Q4 | 1.32 Billion USD | 39.35% |
| 2014 Q1 | 1.12 Billion USD | -10.75% |
| 2013 Q4 | 1.26 Billion USD | 0.88% |
| 2013 Q2 | 1.12 Billion USD | 17.26% |
| 2013 FY | 4.59 Billion USD | 18.44% |
| 2013 Q1 | 956 Million USD | -15.32% |
| 2013 Q3 | 1.25 Billion USD | 11.86% |
| 2012 Q3 | 1 Billion USD | 4.14% |
| 2012 Q2 | 966 Million USD | 24.48% |
| 2012 Q1 | 776 Million USD | -27.07% |
| 2012 FY | 3.87 Billion USD | 12.02% |
| 2012 Q4 | 1.12 Billion USD | 12.23% |
| 2011 Q3 | 868 Million USD | 6.37% |
| 2011 Q1 | 713 Million USD | -30.51% |
| 2011 Q4 | 1.06 Billion USD | 22.58% |
| 2011 FY | 3.46 Billion USD | 0.99% |
| 2011 Q2 | 816 Million USD | 14.45% |
| 2010 Q1 | 771 Million USD | -26.56% |
| 2010 Q4 | 1.02 Billion USD | 26.82% |
| 2010 Q3 | 809 Million USD | -1.46% |
| 2010 Q2 | 821 Million USD | 6.49% |
| 2010 FY | 3.42 Billion USD | -7.28% |
| 2009 Q1 | 738.4 Million USD | -22.5% |
| 2009 FY | 3.69 Billion USD | 15.06% |
| 2009 Q4 | 1.04 Billion USD | 2.79% |
| 2009 Q3 | 1.02 Billion USD | 15.21% |
| 2009 Q2 | 886.5 Million USD | 20.06% |
| 2008 FY | 3.21 Billion USD | 21.81% |
| 2008 Q4 | 952.8 Million USD | 29.46% |
| 2008 Q1 | 748.5 Million USD | -8.16% |
| 2008 Q3 | 736 Million USD | -5.01% |
| 2008 Q2 | 774.8 Million USD | 3.51% |
| 2007 Q4 | 815 Million USD | 18.2% |
| 2007 Q3 | 689.5 Million USD | -4.71% |
| 2007 FY | 2.63 Billion USD | 92.64% |
| 2007 Q2 | 723.6 Million USD | 76.96% |
| 2007 Q1 | 408.9 Million USD | -1.99% |
| 2006 Q1 | 329.6 Million USD | -18.9% |
| 2006 Q2 | 337.9 Million USD | 2.52% |
| 2006 Q3 | 284.2 Million USD | -15.89% |
| 2006 FY | 1.36 Billion USD | 11.77% |
| 2006 Q4 | 417.2 Million USD | 46.8% |
| 2005 FY | 1.22 Billion USD | 33.29% |
| 2005 Q4 | 406.4 Million USD | 60.82% |
| 2005 Q3 | 252.7 Million USD | -8.41% |
| 2005 Q2 | 275.9 Million USD | -4.76% |
| 2005 Q1 | 289.7 Million USD | 13.56% |
| 2004 FY | 918.8 Million USD | 8.44% |
| 2004 Q3 | 184.6 Million USD | -21.28% |
| 2004 Q4 | 255.1 Million USD | 38.19% |
| 2004 Q2 | 234.5 Million USD | -4.13% |
| 2004 Q1 | 244.6 Million USD | -7.14% |
| 2003 Q3 | 187.8 Million USD | -6.01% |
| 2003 FY | 847.3 Million USD | 18.24% |
| 2003 Q2 | 199.8 Million USD | 1.78% |
| 2003 Q4 | 263.4 Million USD | 40.26% |
| 2003 Q1 | 196.3 Million USD | -1.9% |
| 2002 Q1 | 175.7 Million USD | 234.84% |
| 2002 Q3 | 164.4 Million USD | -6.8% |
| 2002 FY | 716.6 Million USD | 73.43% |
| 2002 Q4 | 200.1 Million USD | 21.72% |
| 2002 Q2 | 176.4 Million USD | 0.4% |
| 2001 Q2 | 198 Million USD | -10.69% |
| 2001 FY | 413.2 Million USD | -44.61% |
| 2001 Q1 | 221.7 Million USD | 5.82% |
| 2001 Q3 | 123.7 Million USD | -37.53% |
| 2001 Q4 | -130.3 Million USD | -205.34% |
| 2000 FY | 746 Million USD | 17.46% |
| 2000 Q1 | 191.3 Million USD | 2.68% |
| 2000 Q3 | 158.7 Million USD | -14.91% |
| 2000 Q4 | 209.5 Million USD | 32.01% |
| 2000 Q2 | 186.5 Million USD | -2.51% |
| 1999 Q3 | 121.6 Million USD | -25.22% |
| 1999 Q1 | 164.6 Million USD | 12.89% |
| 1999 Q2 | 162.6 Million USD | -1.22% |
| 1999 Q4 | 186.3 Million USD | 53.21% |
| 1999 FY | 635.1 Million USD | 60.22% |
| 1998 Q2 | 16.2 Million USD | -86.64% |
| 1998 Q4 | 145.8 Million USD | 42.38% |
| 1998 FY | 396.4 Million USD | 951.46% |
| 1998 Q1 | 121.3 Million USD | 9.48% |
| 1998 Q3 | 102.4 Million USD | 532.1% |
| 1997 Q3 | 74.7 Million USD | 132.41% |
| 1997 FY | 37.7 Million USD | -50.0% |
| 1997 Q1 | 58.5 Million USD | -2.66% |
| 1997 Q2 | -230.5 Million USD | -494.02% |
| 1997 Q4 | 110.8 Million USD | 48.33% |
| 1996 Q4 | 60.1 Million USD | -5.65% |
| 1996 Q3 | 63.7 Million USD | 201.76% |
| 1996 Q2 | -62.6 Million USD | -540.85% |
| 1996 Q1 | 14.2 Million USD | 102.15% |
| 1996 FY | 75.4 Million USD | 111.47% |
| 1995 Q3 | -2.5 Million USD | -108.04% |
| 1995 FY | -657.2 Million USD | -313.72% |
| 1995 Q4 | -659.4 Million USD | -26276.0% |
| 1995 Q2 | 31.1 Million USD | 217.8% |
| 1995 Q1 | -26.4 Million USD | -112.41% |
| 1994 Q3 | 51.7 Million USD | 13.38% |
| 1994 FY | 307.5 Million USD | -7.32% |
| 1994 Q2 | 45.6 Million USD | 1924.0% |
| 1994 Q1 | -2.5 Million USD | -101.05% |
| 1994 Q4 | 212.7 Million USD | 311.41% |
| 1993 Q2 | 74.5 Million USD | 443.32% |
| 1993 FY | 331.8 Million USD | 148.73% |
| 1993 Q1 | -21.7 Million USD | -277.87% |
| 1993 Q4 | 237.5 Million USD | 472.29% |
| 1993 Q3 | 41.5 Million USD | -44.3% |
| 1992 Q2 | 77.9 Million USD | 708.59% |
| 1992 Q3 | 56.1 Million USD | -27.98% |
| 1992 FY | 133.4 Million USD | -61.52% |
| 1992 Q4 | 12.2 Million USD | -78.25% |
| 1992 Q1 | -12.8 Million USD | -105.48% |
| 1991 Q4 | 233.7 Million USD | 320.32% |
| 1991 FY | 346.7 Million USD | -10.02% |
| 1991 Q1 | -2.4 Million USD | -101.02% |
| 1991 Q2 | 59.8 Million USD | 2591.67% |
| 1991 Q3 | 55.6 Million USD | -7.02% |
| 1990 Q4 | 235 Million USD | 265.47% |
| 1990 Q3 | 64.3 Million USD | -17.88% |
| 1990 Q2 | 78.3 Million USD | 903.85% |
| 1990 FY | 385.3 Million USD | -3.22% |
| 1990 Q1 | 7.8 Million USD | -96.72% |
| 1989 Q1 | 24.2 Million USD | 0.0% |
| 1989 Q3 | 74.1 Million USD | 20.29% |
| 1989 Q2 | 61.6 Million USD | 154.55% |
| 1989 FY | 398.1 Million USD | 12.3% |
| 1989 Q4 | 238.1 Million USD | 221.32% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 6195.628% |
| Accuray Incorporated | -15.54 Million USD | 53776.423% |
| Align Technology, Inc. | 445.05 Million USD | -1774.833% |
| Elevance Health Inc. | 5.98 Billion USD | -39.369% |
| AxoGen, Inc. | -21.71 Million USD | 38523.282% |
| Boston Scientific Corporation | 1.59 Billion USD | -423.792% |
| Cardinal Health, Inc. | 852 Million USD | -879.343% |
| Centene Corporation | 2.7 Billion USD | -208.808% |
| DaVita Inc. | 691.53 Million USD | -1106.591% |
| HCA Healthcare, Inc. | 5.24 Billion USD | -59.176% |
| Hologic, Inc. | 789.5 Million USD | -956.871% |
| Humana Inc. | 2.48 Billion USD | -235.235% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -887.407% |
| Laboratory Corporation of America Holdings | 418 Million USD | -1896.172% |
| Masimo Corporation | 81.5 Million USD | -10138.037% |
| McKesson Corporation | 3 Billion USD | -177.948% |
| Patterson Companies, Inc. | 185.93 Million USD | -4387.686% |
| Quest Diagnostics Incorporated | 854 Million USD | -877.049% |
| ResMed Inc. | 1.02 Billion USD | -717.277% |
| Henry Schein, Inc. | 416 Million USD | -1905.769% |
| Teladoc Health, Inc. | -220.36 Million USD | 3886.394% |
| Universal Health Services, Inc. | 717.79 Million USD | -1062.449% |
| Veeva Systems Inc. | 525.7 Million USD | -1487.202% |
| Baxter International Inc. | 2.65 Billion USD | -214.157% |
| Becton, Dickinson and Company | 1.48 Billion USD | -462.264% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -364.071% |
| Danaher Corporation | 4.2 Billion USD | -98.667% |
| Stryker Corporation | 3.16 Billion USD | -163.633% |
| Medtronic plc | 3.67 Billion USD | -126.986% |